Complement inhibition for improved nerve regeneration
US8703136B2 · kind B2 · utility
26Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2007 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Aug 16, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and medicaments used for treating conditions that require axonal regeneration, e.g. in mammals affected by injury or disease of the central or peripheral nervous system. The medicaments used in these methods facilitate axonal regeneration by inhibition of the complement system. Conditions requiring axonal regeneration that may be treated in accordance with the invention include physical injuries as well as neurodegenerative disorders of the peripheral or central nervous system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.